Skip to main content
Skip to main content
Home
Cohorts
Resources
Gefos Data Release
Data Release 2012
Data Release 2015
Data Release 2017
Adult Lean mass GWAS 2017
UKBB eBMD GWAS Data Release 2017
LifeCourse TB-BMD GWAS 2017
Data Release 2017 EWAS
Data Release 2018
Estrogen GWAS 2018
Fracture GWAS 2018 Release
Human osteoclast eQTL 2018-2020
Mandibular Coritical Indices GWAS 2024
Skeletal age GWAS 2021
Skull BMD GWAS 2023
UKBB FALLS GWAS Data Release 2020
Programs
Forms
Papers
Official Documents
Press Releases
Research
Publications
Community
News
Events
20th GENOMOS Investigators meeting - Stockholm
7th GEFOS / 17th GENOMOS Investigators meeting
8th GEFOS / 18th GENOMOS Investigators meeting
Calendar
Forums
Blogs
Details
Partners
Contact
GEFOS-SEQ Horizon2020 Application
Search form
Search
User login
Username
*
Password
*
Request new password
You are here
Home
Framingham Osteoporosis Study
General Information
Participation in GEFOS (GWA):
Yes
Participation in GENOMOS:
Yes
Who represents the study?:
Kiel, Douglas P.
Affiliation:
Hebrew SeniorLife
From which COUNTRY is the study coming from?:
United States
City/Region:
Boston, MA
Base of the study:
Population-based
Family-based
Type of Population:
Outbred
Design of the study:
Longitudinal
Ethnicity:
Caucasian
Minimum Age:
30
Maximum Age:
96
Total number of MEN:
4 264
Total number of WOMEN:
5 008
GWA Data
GWA Data Available:
Yes
GWA Affymetrix Genechip 100k platform:
9 272
GWA Affymetrix Genechip 500k Duo (NspI/StyI) platform:
9 272
Date GWA data is available:
03-17-08
WHO Risk Score Data
Age:
Yes
Height:
Yes
Weight:
Yes
BMI:
Yes
Postmenopausal status:
Yes
Age menopause:
Yes
Glucocorticoid use:
Yes
Rheumatoid arthritis:
Yes
Smoking history:
Yes
Alcohol consumption:
Yes
Does the study have information on physical activity of participants?:
Yes
Does the study have information on dietary intake of participants?:
Yes
Related information
Cohort
Framingham Osteoporosis Study